BIOTECH INSIGHTS

Big Pharma Dives Into CBD: Who Could Be Next?

As many of you know, Jazz Pharmaceuticals plc (NASDAQ: JAZZ) agreed in early February to acquire GW Pharmaceuticals plc (NASDAQ: GWPH) for a total...

BIOTECH NEWS

Big Pharma Dives Into CBD: Who Could Be Next?

As many of you know, Jazz Pharmaceuticals plc (NASDAQ: JAZZ) agreed in early February to acquire GW Pharmaceuticals plc (NASDAQ: GWPH) for a total...

Cardiol Therapeutics Announces Completion of Phase I Clinical Study of CardiolRx™

Study results are expected to support the Company's plans to file an IND application with the FDA for a Phase II clinical trial in...
Advertisement

CEO INTERVIEWS

BiotechStocktrader Interview with Nader Pourhassan, CEO of Cytodyn, Inc.

In this episode of Biotech Stocktrader, we are joined by Dr. Nader Pourhassan, President and CEO of CytoDyn, a biotechnology company developing innovative treatments...

BiotechStocktrader Interview with Dr. Carl Schwartz, CEO of Precision Therapeutics, (AIPT).

In this episode of BiotechStocktrader we are joined by Dr. Carl Schwartz, CEO of Precision Therapeutics, ticker AIPT. About Precision Therapeutics Inc. Precision Therapeutics (AIPT)...